We get a large number of questions on individual drugs. Unfortunately, most of the robust resources ‘hide behind’ a firewall and require an expensive subscription to obtain the information. It’s a bit like the Cochrane situation (see previous post) in that (I imagine) the taxpayers have paid for the initial research and development and then have to pay for re-accessing the same information.
I accept that many of these resources require significant input regarding appraising, searching, editing etc. So what’s the solution, perhaps via another great resource highlighted on Ben’s blog. This time it’s an open-access, wiki-based, drug resource called PubDrug. It again highlights what can be done with decent tools (wiki) and a bunch of skilled and enthusiastic individuals. Currently, it has 7 monographs. I hope this expands rapidly.